CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis
Shunya Kaneshita, Takashi Kida, Makoto Yoshioka, Keisuke Nishioka, Mithun Raje, Aki Sakashita, Aiko Hirano, Tomoya Sagawa, Akiko Kasahara, Takuya Inoue, Kazuki Fujioka, Hidetake Nagahara, Makoto Wada, Masataka Kohno, Jeffrey Strovel, Steven Fletcher, Eishi Ashihara, Yutaka Kawahito
Topics & Concepts
Pulmonary fibrosisBleomycinAutocrine signallingParacrine signallingCancer researchFibrosisTransforming growth factorMyofibroblastMedicineBiologyPathologyInternal medicineReceptorChemotherapyProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisMultiple Myeloma Research and Treatments